Outcomes vary by patient
It is linked to elevated levels of fibrinogen and C-reactive protein, diabetes, insulin resistance, dyslipidemia, and hypertension, all of which raise the risk of CVD events ( It is less evident how GLP-1 agonists directly affect arrhythmias, some studies suggest they may reduce frequency of arrythmias because their favorable effects on metabolism and over all cardiovascular health
Timeline: When Side Effects Occur Understanding when to expect side effects helps you plan and recognize normal patterns versus concerning developments
Wegovy (Oral) Wegovy (semaglutide) pill, a FDA-approved GLP-1 receptor agonist, taken once a day, to help regulate appetite and feelings of fullness
Most participants who experienced nausea during the initial titration phase reported significant improvement or complete resolution by weeks 4 to 8 at a stable dose
Institute of Medicine (US) Subcommittee on Military Weight Management